Phase 1 anti-cancer vaccine study shows great promise

Madely Health Headlines Commentary for September 1, 2011

Source:

Canadian-made virus shows promise as cancer treatment

Reference:

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans